Letrozole, a non-steroidal aromatase inhibitor, was used to induce PCOS-like characteristics, because it reliably mimics the reproductive and metabolic features of PCOS in humans, including increased androgen levels, polycystic ovaries, irregular estrous cycles, and metabolic irregularities [23,25]. This evidence concerns the gene CYP19A1 and polycystic ovary syndrome.